ERBB2 and breast carcinoma: In contrast, EpCAM demonstrated greater efficiency in capturing significant amounts of EVs from the MCF7, BT-474, and SK-BR-3 cell lines, which represent luminal and HER2 breast cancer subtypes with epithelial characteristics.